{"id":"W3128527220","doi":"10.1038/s41598-021-83317-7","title":"Pembrolizumab in vaginal and vulvar squamous cell carcinoma: a case series from a phase II basket trial","year":2021,"lang":"en","type":"article","venue":"Scientific Reports","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"University of Texas MD Anderson Cancer Center; National Institutes of Health; National Cancer Institute; Fondation du cancer des Cèdres; U.S. Department of Health and Human Services","keywords":"Pembrolizumab; Medicine; Response Evaluation Criteria in Solid Tumors; Discontinuation; Vulvar Carcinoma; Vulva; Internal medicine; Oncology; Population; Vaginal disease; Vulvar neoplasm; Chemotherapy; Vagina; Surgery; Dermatology; Progressive disease; Cancer; Immunotherapy","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007767063,0.0005019951,0.000662946,0.0004874984,0.0008674428,0.001265959,0.000411951,0.00158535,0.001359097],"category_scores_gemma":[0.002760012,0.0002652513,0.0005473974,0.0007601181,0.0004281511,0.0006276389,0.0004292854,0.001079558,0.0004205684],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00063217,"about_ca_system_score_gemma":0.0005294416,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007207288,"about_ca_topic_score_gemma":0.001350094,"domain_scores_codex":[0.999499,0.0001130286,0.00007021616,0.00007235157,0.0001259763,0.0001194953],"domain_scores_gemma":[0.9987265,0.0004120446,0.0003147306,0.0001422875,0.00009729827,0.0003070616],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"case_report","study_design_gemma":"observational","study_design_scores_codex":[0.002669383,0.001372028,0.18571,0.0006895067,0.0003211272,0.6747081,0.0009949399,0.0008189962,0.01144836,0.002323896,0.009889259,0.1090544],"study_design_scores_gemma":[0.0005786411,0.001493882,0.03935149,0.0001316971,0.0002161099,0.9400784,0.0004108208,0.001256779,0.003985119,0.0005565693,0.011918,0.00002259848],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9740976,0.0112922,0.001867317,0.001628286,0.0001241811,0.0004475612,0.0002520898,0.0000656082,0.01022519],"genre_scores_gemma":[0.9939734,0.002933027,0.0006910074,0.0008316461,0.0001442402,0.00007429224,0.0002741581,0.00002227031,0.001055975],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00158535,"threshold_uncertainty_score":0,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01760156746138532,"score_gpt":0.2775365031636543,"score_spread":0.259934935702269,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}